LYMPHATIC EDUCATION & RESEARCH NETWORK INC (LE&RN)

EIN: 582404527 501(c)(3) Medical Research

NEW YORK, NY

Total Revenue
$1,283,221
Total Expenses
$1,770,505
Total Assets
$3,590,003
Net Assets
$3,124,699
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1998
Legal Domicile
NY
Principal Officer
WILLIAM REPICCI
Phone
5166259675
Tax Period
2025-01-01 to 2025-12-31

LYMPHATIC EDUCATION & RESEARCH NETWORK INC (LE&RN), founded in 1998, is a community nonprofit in the Medical Research sector that reported $1.3M in total revenue in fiscal year 2025. Revenue fell 27% from the prior year — a significant decline worth monitoring. Expenses of $1.8M exceeded revenue, resulting in a 38% operating deficit.

Mission

THE ORGANIZATION'S MISSION IS TO FIGHT LYMPHATIC DISEASES AND LYMPHEDEMA THROUGH EDUCATION, RESEARCH AND ADVOCACY. THE ORGANIZATION SEEKS TO ACCELERATE THE PREVENTION, TREATMENT, AND CURE OF LYMPHATIC DISEASES WHILE BRINGING PATIENTS AND MEDICAL PROFESSIONALS TOGETHER TO ADDRESS THE UNMET NEEDS SURROUNDING LYMPHATIC DISORDERS.

Program Service Accomplishments

Program 1
Expenses: $1,442,732 Revenue: $1,169,710

Some activities of the organization during 2025 include the following: LE&RN continued to expand programs to meet the goals of the expanded mission of fighting lymphatic disease through education...

Read more

Some activities of the organization during 2025 include the following: LE&RN continued to expand programs to meet the goals of the expanded mission of fighting lymphatic disease through education, research, and advocacy. LE&RN continued its grant program, which allows young investigators to attend conferences focused on lymphatic research. LE&RN continued its educational and awareness outreach programs targeting academia, government, industry, and the medical and patient communities. LE&RN continued its monthly virtual symposium series, which brings the world's foremost authorities in lymphatic disease and lymphedema to patients, their families, and professionals. LE&RN updated its website and provided daily social media posts and monthly newsletters featuring significant events in the field. LE&RN produced six issues of Lymphatic Research and Biology, an international, peer-reviewedbiomedical journal providing a forum for the exchange of cutting-edge scientific developments in lymphatic science and medicine. LE&RN secured ongoing support from the Congressional and National Institutes of Health for lymphatic research. LE&RN continued the LE&RN/LymphNotes Lymphedema Scholarship Program to provide tuition support to therapists seeking certification in lymphedema therapy. LE&RN continued a web-based "Ask the Experts" feature that allows patients, their families, and professionals to ask the most prominent authorities in the field questions directly. LE&RN spokesperson and Academy Award Winner Kathy Bates appeared in print and television media to support research. LE&RN's Virtual Expo was expanded to better serve patients and therapists. LE&RN and NAVBO prepared a biennial Virtual Lymphatic Forum for researchers LE&RN developed new chapters in several states and countries. LE&RN continued to lead global events related to its establishment of World Lymphedema Day on March 6, 2016. LE&RN supported and grew its Centers of Excellence in the Diagnosis & Treatment of Lymphatic Diseases to 80 member institutions in over 20 countries. LE&RN, in collaboration with Stanford University, hosted the annual virtual State-of-the-Art Summit in Lymphatic Research & Medicine. LE&RN promoted its PSA video featuring National Spokesperson Kathy Bates, which was hosted on the Centers for Disease Control and Prevention (CDC) 's cancer-related websites. LE&RN continued its cancer-related lymphedema campaign. LE&RN succeeded in having the Congressionally Directed Medical Research Program (CDMRP) include lymphedema as a category in the Department of Defense's Peer Reviewed Medical Research Program (PRMRP). LE&RN successfully requested that Congress establish a National Commission on Lymphatic Diseases at the National Institutes of Health (NIH). LE&RN established a global Patient Resource Center. LE&RN expanded and updated its Global Patient Registry. LE&RN successfully advocated for a Program Manager in Lymphatics at the Advanced Research Agency for Health (ARPA-H) LE&RN, in concert with the research community, created a "Gaps in Lymphatic Research" document that was distributed to the NIH, CDC, ARPA-H, CDMRP, NNLBI, and NIAID. LE&RN hired its first full-time Vice President of Scientific Affairs and Science and Medical Director.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $1,142,651
Program Service Revenue $0
Investment Income $113,511
Other Revenue $27,059
TOTAL REVENUE $1,283,221

Expense Breakdown

Grants Paid $23,618
Salaries & Benefits $1,158,508
Fundraising Expenses $164,192
Program Expenses $1,442,732
Other Expenses $588,379
TOTAL EXPENSES $1,770,505

Year-over-Year Comparison

2025 2024 Change
Revenue $1,283,221 $1,755,810 -0.3%
Expenses $1,770,505 $1,651,386 +0.1%
Net Income $-487,284 $104,424 -5.7%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
6
Independent Members
6
Employees
10
Volunteers
6

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$372,407
Total Directors
7
$0
Key Employees
0
$0
Highest Compensated
1
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JOSEPH DAYAN MD DIRECTOR 1.00
Director
$0 $0 $0
Dr Emily Iker DIRECTOR 1.00
Director
$0 $0 $0
MELISSA ALDRICH PHD CHAIRPERSON 10.00
Officer Director
$0 $0 $0
RICK PETTY DIRECTOR 1.00
Director
$0 $0 $0
Liz Basaca TREASURER 1.00
Director
$0 $0 $0
DORON ILAN MD SECRETARY 1.00
Director
$0 $0 $0
Jonathan Ross DIRECTOR 1.00
Director
$0 $0 $0
WILLIAM REPICCI PRESIDENT & CEO 40.00
Officer
$314,640 $57,767 $372,407
Maria Celia Dupecher Vice President for Scientific Affairs 40.00
Highest
$146,250 $0 $146,250
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $1,283,221 $1,770,505 $3,590,003 $-487,284
2025 $1,283,221 $1,770,505 $3,590,003 $-487,284
2024 $1,755,810 $1,651,386 $4,009,793 $104,424
2023 $1,476,365 $1,736,198 $3,828,174 $-259,833
2022 $1,462,533 $1,490,145 $3,910,350 $-27,612
2021 $4,129,686 $997,532 $3,889,093 $3,132,154
2020 $894,003 $731,503 $654,052 $162,500
2019 $1,001,853 $866,648 $501,469 $135,205
2018 $912,615 $867,921 $352,714 $44,694
Explore More Nonprofits
Top 100 Nonprofits in New York Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare LYMPHATIC EDUCATION & RESEARCH NETWORK INC (LE&RN) with other nonprofits in New York and across the country.